Literature DB >> 20493607

Severe hypomagnesemia during long-term treatment with a proton pump inhibitor.

Giuseppe Regolisti1, Aderville Cabassi, Elisabetta Parenti, Umberto Maggiore, Enrico Fiaccadori.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20493607     DOI： 10.1053/j.ajkd.2010.03.013

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN： 0272-6386            Impact factor:   8.860


× No keyword cloud information.
  28 in total

1.  Long-Term Proton Pump Inhibitor Use Is Not Associated With Changes in Bone Strength and Structure.

Authors:  Laura E Targownik; Andrew L Goertzen; Yunhua Luo; William D Leslie
Journal:  Am J Gastroenterol       Date:  2016-11-15       Impact factor: 10.864

2.  Proton-pump inhibitors do not influence serum magnesium levels in renal transplant recipients.

Authors:  Charlotte Van Ende; Steven Van Laecke; Celine Marechal; Francis Verbeke; Nada Kanaan; Eric Goffin; Raymond Vanholder; Michel Jadoul
Journal:  J Nephrol       Date:  2014-05-10       Impact factor: 3.902

3.  Evaluation of electrolyte repletion in hematopoietic cell transplant patients receiving H-2 receptor antagonists or proton pump inhibitors.

Authors:  K Smith; M L Gatesman; S E Harpe; W Clark
Journal:  Bone Marrow Transplant       Date:  2014-05-12       Impact factor: 5.483

4.  Association of Proton Pump Inhibitor Use with Recurrent Falls and Risk of Fractures in Older Women: A Study of Medication Use in Older Fallers.

Authors:  H W Thaler; C S Sterke; T J M van der Cammen
Journal:  J Nutr Health Aging       Date:  2016-01       Impact factor: 4.075

Review 5.  Adverse effects of long-term proton pump inhibitor therapy.

Authors:  Edward Sheen; George Triadafilopoulos
Journal:  Dig Dis Sci       Date:  2011-03-02       Impact factor: 3.199

6.  Use of proton pump inhibitors is associated with lower trabecular bone density in older individuals.

Authors:  Marcello Maggio; Fulvio Lauretani; Gian Paolo Ceda; Francesca De Vita; Giuliana Bondi; Andrea Corsonello; Chiara Cattabiani; Fabrizia Lattanzio; Carmelinda Ruggiero; Antonio Nouvenne; Tiziana Meschi; Stefania Bandinelli; Luigi Ferrucci
Journal:  Bone       Date:  2013-09-26       Impact factor: 4.398

7.  Proton-pump inhibitor use is associated with low serum magnesium concentrations.

Authors:  John Danziger; Jeffrey H William; Daniel J Scott; Joon Lee; Li-wei Lehman; Roger G Mark; Michael D Howell; Leo A Celi; Kenneth J Mukamal
Journal:  Kidney Int       Date:  2013-01-16       Impact factor: 10.612

8.  Long-term proton pump inhibitor use is associated with vascular calcification in chronic kidney disease: a cross-sectional study using propensity score analysis.

Authors:  Maria Fusaro; Marianna Noale; Giovanni Tripepi; Sandro Giannini; Angela D'Angelo; Angelo Pica; Lorenzo A Calò; Davide Miozzo; Maurizio Gallieni
Journal:  Drug Saf       Date:  2013-08       Impact factor: 5.606

9.  Out-of-hospital use of proton pump inhibitors and hypomagnesemia at hospital admission: a nested case-control study.

Authors:  Ioannis Koulouridis; Mansour Alfayez; Hocine Tighiouart; Nicolaos E Madias; David M Kent; Jessica K Paulus; Bertrand L Jaber
Journal:  Am J Kidney Dis       Date:  2013-05-10       Impact factor: 8.860

10.  Omeprazole enhances the colonic expression of the Mg(2+) transporter TRPM6.

Authors:  A L L Lameris; M W Hess; I van Kruijsbergen; J G J Hoenderop; R J M Bindels
Journal:  Pflugers Arch       Date:  2013-06-12       Impact factor: 3.657
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.